
Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 - Science and Medicine Group
Description
Kalorama Information’s Women’s Health Diagnostic Markets: Global Outlook and Forecast to 2030 offers a comprehensive, data-driven analysis of the global landscape for diagnostic tests that specifically address women’s health across clinical, point-of-care (POC), and over-the-counter (OTC) settings. As global demographics shift—with women living longer than men—healthcare systems are under increasing pressure to recognize and address sex-based differences in disease risk, screening, and treatment. Diagnostics are at the core of this transformation, offering the ability to deliver personalized and timely interventions across a woman’s life span.
This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.
Key diagnostic sectors covered in the report include:
A diverse group of diagnostic players—ranging from dominant multinationals to nimble niche firms—are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women's diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.
At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women’s health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women’s evolving health needs.
Please Note: Single user allows for up to 3 users for this report.
This in-depth report forecasts global market revenues for diagnostic tests and systems through 2030, providing regional segmentation and trend analysis across a broad spectrum of diagnostic categories relevant to female health. The study encompasses both established and emerging technologies used in the detection, screening, and monitoring of conditions unique to, or highly prevalent among, women. Market sizing reflects product and system sales, including associated services such as instrument installation and software support.
Key diagnostic sectors covered in the report include:
- Breast and Reproductive Health Imaging: Mammography, CADe/CADx, OB/GYN ultrasound, and breast ultrasound imaging.
- Prenatal and Carrier Screening: Non-invasive prenatal testing (NIPT), carrier screening, and maternal-fetal diagnostics.
- Infectious and Sexually Transmitted Diseases: HPV diagnostics, TORCH immunoassays, and molecular urinary tract infection (UTI) testing.
- Fertility and Pregnancy Testing: Lab-based and POC tests for ovulation, fertility hormones, and pregnancy status.
- Cancer and Chronic Disease Monitoring: Pap tests, ovarian cancer biomarkers, and female-specific autoimmune immunoassays.
- Bone Health and Preventive Diagnostics: Bone densitometry testing and colposcopy systems for early cancer detection.
A diverse group of diagnostic players—ranging from dominant multinationals to nimble niche firms—are profiled in each category. Companies covered include BD, GE Healthcare, Hologic, Roche, Siemens Healthineers, and Thermo Fisher, among others. These firms are actively shaping the future of women's diagnostics through innovation in biomarkers, automation, digital imaging, and home-based testing.
At a time when diagnostic testing influences more than 70% of medical decisions, this report positions women’s health diagnostics not only as a growing market but also as a critical component of precision medicine. The insights contained herein are essential for stakeholders focused on expanding access, improving clinical outcomes, and investing in the next generation of diagnostic solutions tailored to women’s evolving health needs.
Please Note: Single user allows for up to 3 users for this report.
Table of Contents
210 Pages
- Overview
- Scope and Methodology
- Market Overview and Potential
- Female Health: Room for Improvement
- Perspective on Women’s Health
- Women and Men Develop Some Diseases Differently
- Key Trends and Issues in Women’s Health Diagnostics
- Introduction
- Mammography Market
- Computer-Aided Detection/Diagnosis (CADe/CADx)
- Artificial Intelligence Adoption in Breast Imaging
- Regulatory Changes
- Competitive Landscape
- Introduction
- Obstetrics and Gynecology
- Breast Imaging
- Market Trends
- Obstetric and Gynecological Ultrasound Trends
- Breast Imaging Market
- Competitive Landscape
- Introduction
- NIPT
- Advances in Genetics Bring New Challenges
- Carrier Screening
- Test Adoption Trends
- Inherited Diseases
- M&A, Partnerships
- NIPT and Carrier Screening Markets
- Competitive Landscape
- Introduction
- Overview
- HPV IVD Test Market
- Competitive Landscape
- Introduction
- Perspective on Testing
- Digital Testing
- Lab Testing
- Trends
- Market
- Products
- TORCH Testing
- Competitive Landscape
- Introduction
- Testing for Cervical Cancer
- Trends
- Pap Test Market
- Competitive Landscape
- Introduction
- Genetic Factors
- Impact on Female Patients
- Recent Developments
- Female Autoimmune Lab-Based Immunoassay Market
- Competitive Landscape
- Introduction
- Alarming Rise in Osteoporosis
- Propelling the Need for Measurement
- Trends in DEXA and Competing Technologies
- Bone Densitometry Market
- Competitive Landscape
- Introduction
- Cervical Cancer Screening and Diagnosis
- Trends
- Colposcopy Systems Market
- Competitive Landscape
- Introduction
- Leading Cause of Morbidity and Death
- Impact
- Trends
- Technological Advances Outpace Clinical Guidelines
- Next-Generation Sequencing (NGS)
- Multiplex PCR, qPCR
- UTI Molecular Test Market
- Competitive Landscape
- Introduction
- Types of Ovarian Cancer
- CA-125
- Trends
- Multivariate Index Assays and Genomic Tests
- Ovarian Cancer Biomarker Market
- Competitive Landscape
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.